BioCardia’s data safety monitoring board already warned that the phase 3 CardiAMP cell therapy heart failure trial was not going to make the primary endpoint. And so the California biotech is ...
Tectonic Therapeutic, Inc.'s stock surged 120% after positive Phase 1b data for TX45 in treating PH-HFpEF, a condition with no approved therapies. TX45, an Fc-relaxin fusion protein, showed promising ...
You are tasked to lead a 40-truck convoy resupplying combat troops at the front during large-scale combat operations. The mission is critical, and every vehicle must complete it as quickly, ...
Add Yahoo as a preferred source to see more of our stories on Google. CNN’s data guru foresees that the president’s “failure, failure, failure” will defeat the GOP in the midterms. The 37-year-old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results